Loading stock data…
$1.38-0.10 (-6.76%)
MindWalk Holdings Corp.
MindWalk Holdings Corp. in the Healthcare sector is trading at $1.41 with a market capitalization of $66M. Wall Street consensus targets $4.33 (3 analysts), implying a +207.3% move over the next 12 months. The stock is currently 53% below its 52-week high of $2.99, remaining 3.4% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.12M↓ | $4.16M↑ | $4.12M↑ | $3.16M↓ | $6.98M |
| Gross Profit | $2.50M↑ | $2.46M↓ | $2.66M↑ | $1.53M↓ | $4.46M |
| Operating Income | -$4.33M↓ | -$3.66M↓ | -$2.76M↑ | -$4.15M↓ | -$1.46M |
| Net Income | -$3.87M↑ | -$3.93M↓ | -$3.19M↓ | -$2.96M↓ | -$2.16M |
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was form...